NCT00734773 2012-05-18
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
Northwestern University
Phase EARLY_PHASE1 Withdrawn
Clinical Trials
3 trialsNCT00290004 2008-09-11
Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Pharmacyclics LLC.
Phase 1/2 Completed
NCT00086034 2007-05-15
Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma
Pharmacyclics LLC.
Phase 2 Completed